Author:
Yarchoan Robert,Mitsuya Hiroaki
Reference104 articles.
1. Ahluwalia G, Cooney DA, Mitsuya H, Fridland A, Flora KP, Hao Z et al (1987) Initial studies on the cellular pharmacology of 2′,3′-dideoxyinosine, an inhibitor of HIV infectivity. Biochem Pharmacol 36(33):3797–3800
2. Ahluwalia GS, Dedrick RL, Driscoll JS, Morrison PF, Gao W-Y, Johns DG (1997) Decay rates of anti-HIV dideoxynucleotides in tissue culture systems: a simple correction for the effect of cell replication. Drug Metab Dispos 25(7):893–896
3. Altman LK (1984, April 24, 1984) New U.S. report names virus that may cause AIDS. New York Times.
http://partners.nytimes.com/library/national/science/aids/042484sci-aids.html?scp=5&sq=1983%20Gallo%20Heckler&st=cse
. Accessed April 24, 2013
4. Barre-Sinoussi F, Chermann JC, Rey F, Nugeyre T, Charmaret S, Gruest J et al (1983) Isolation of a T-cell lymphotropic virus from a patient at risk for the acquired immunodeficiency syndrome (AIDS). Science 220:868–871
5. Bonjoch A, Paredes R, Galvez J, Miralles C, Videla S, Martinez E et al (2005) Antiretroviral treatment simplification with 3 NRTIs or 2 NRTIs plus nevirapine in HIV-1-infected patients treated with successful first-line HAART. J Acquir Immune Defic Syndr 39(3):313–316